VJHemOnc is committed to improving our service to you

MDS 2020 | Patient advocates for clinical trials

VJHemOnc is committed to improving our service to you

Rena Buckstein

Rena Buckstein, MD, FRCPC, Odette Cancer Research Program, Sunnybrook Research Institute, Toronto, Canada, discusses having more inclusive clinical trial criteria, and the need to encourage patients to become advocates for clinical trials. This interview took place at the 2nd Regional Symposium on Myelodysplastic Syndromes (MDS 2020), held in Tel Aviv, Israel.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter